PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

To evaluate PK and PD responses to L-citrulline given orally for four weeks to patients with sickle cell disease who are otherwise healthy.

Phase 1

Angiogenix